LAS VEGAS, NV--(Marketwired - Sep 14, 2016) - Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), introduced Vault Mapping for all iSeries OCT systems this week at the International Vision Expo West, Sept. 15-17. The new Vault Mapping software can be used to assist in scleral lens fitting by allowing visualization and mapping of the central corneal clearance (CCC), a key measurement related to how well the lens rests on the eye.
Optovue also introduced its proprietary AngioVue™ Imaging System to the optometry market and announced two in-booth presentations -- one on Vault Mapping by Jeffrey Sonsino, OD, and one on AngioVue OCTA by Nathan Lighthizer, OD. The presentations will take place in Optovue's booth (MS5035) on Thursday, Sept. 15, from 4:00 - 6:00 pm at the Sands Expo & Convention Center.
"Corneal clearance is critical when fitting patients for scleral lenses," said Mile Brujic, OD, FAAO, partner, Premier Vision Group, Bowling Green, Ohio. "The new Vault Mapping capability has allowed this process to become more efficient and convenient than merely estimating this clearance by a slit lamp visual exam, which is the current standard of care. This is truly a technology that all scleral lens fitters should consider incorporating into their practice."
A scleral lens is a large contact lens that rests on the white portion of the eye (sclera) and is typically used to correct refractive errors in patients with irregular corneas, manage ocular surface disease such as dry eye, or may be worn by athletes who require excellent visual acuity and a stable lens fit during rigorous physical activity.
Traditional corneal imaging for identifying the clearance (vault) between the cornea and a scleral lens utilizes a fluorescein solution and a slit lamp, which results in one cross-sectional view. With Vault Mapping, a CCC assessment map is created, and the clearance pattern can be used to help determine if the lens is tilting or fitting improperly.
The company's new AngioVue Imaging System for optometry provides essential OCT imaging along with OCTA that quickly visualizes retinal microvasculature non-invasively without the use of injection dye. For the first time, optometrists will have information about retinal vascular structures that may be integrated with other imaging results to form a more complete picture of retinal health.
"We are extremely pleased to launch our advanced AngioVue Imaging System for optometry and introduce Vault Mapping for our iSeries systems at the Vision Expo West," said John Hawley, vice president of Global Sales for Optovue. "Vault Mapping is a new feature that adds to an already strong set of anterior segment measurement tools. And for the posterior segment, AngioVue OCTA imaging adds information about vascular structures to give optometrists a new imaging modality to help manage their patients with chronic retinal disease."
Optovue, Inc. is a privately held medical device company founded in 2003. Headquartered in Fremont, Calif., the company is dedicated to the advancement and commercialization of high-speed OCT and OCTA technology used to facilitate the diagnosis and management of eye diseases, many of which may lead to permanent blindness. Optovue is the first company to develop and commercialize the pioneering OCTA technology. To date, there are over 100 peer-reviewed publications detailing the AngioVue Imaging System technology and clinical applications. The company has installed over 10,000 products worldwide and employs over 170 people. For more information, visit www.optovue.com.